Enhancement of percutaneous absorption of naproxen by phospholipids

International Journal of Pharmaceutics

Volumn 175, Issue 2, 1998, Pages 225-230

  Valjakka Koskela, Riitta ^a   Kirjavainen, Merja ^b   Mönkkönen, Jukka ^b   Urtti, Arto ^b   Kiesvaara, Juha ^a  

^a ORION CORPORATION   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Ethanol; Gel; Naproxen; Percutaneous absorption; Phospholipid

Indexed keywords

ALCOHOL; NAPROXEN; PHOSPHOLIPID; PROPYLENE;

ARTICLE; CONTROLLED STUDY; DIFFUSION CHAMBER; DRUG FORMULATION; FEMALE; GEL; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; SKIN ABSORPTION; SKIN PENETRATION;

EID: 0031740481     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(98)00285-3     Document Type: Article

References (16)

1. Barry B.W. Mode of action of penetration enhancers in human skin. J. Control. 6:1987;85-97. Release.
2. Foldvari M., Gesztes A., Mezei M. Dermal drug delivery by liposome encapsulation: Clinical and electron microscopic studies. J. Microencapsul. 7:1990;479-489.
3. Ganesan M.G., Weiner N.D., Flynn G.L., Ho N.F.H. Influence of liposomal drug entrapment on percutaneous absorption. Int. J. Pharm. 20:1984;139-154.
4. Kato A., Ishibashi Y., Miyake Y. Effect of egg yolk lecithin on transdermal delivery of bunazosin hydrochloride. J. Pharm. Pharmacol. 39:1987;399-400.
5. Kimura T., Nagahara N., Hirabayashi K., Kurosaki Y., Nakayama T. Enhanced percutaneous penatration of flumenamic acid using lipid disperse systems containing glycosylceramides. Chem. Pharm. Bull. 37:1989;454-457.
6. Kirjavainen M., Urtti A., Jääskeläinen I., Suhonen M., Paronen P., Valjakka-Koskela R., Kiesvaara J., Mönkkönen J. Interaction of liposomes with human skin in vitro - the influence of lipid composition and structure. Biochim. Biophys. Acta. 1304:1996;179-189.
7. Kirjavainen M., Urtti A., Valjakka-Koskela R., Kiesvaara J., Mönkkönen J. Liposome - skin interactions and their effects on the skin permeation of drugs. Eur. J. Pharm. Sci. 1998;. (in press).
8. Mahjour M., Mauser B., Rashidbaigi Z., Fawzi M.B. Effect of egg yolk lecithin and commercial soybean lecithin on in vitro skin permeation of drugs. J. Control. 14:1990;243-252. Release.
9. Nishihata T., Kotera K., Nakano Y., Yamazaki M. Rat percutaneous transport of diclofenac and influence of hydrogenated soya phospholipids. Chem. Pharm. Bull. 35:1987;3807-3812.
10. Singh P., Roberts M.S. Skin permeability and local tissue concentrations of nonsteroidal anti-inflammatory drugs after topical application. J. Pharmacol. Exp. Ther. 268:1994;144-151.
11. Storm G., Oussoren C., Peeters P.A.M. Safety of liposome administration. Vigo-Pelfrey C. Membrane Lipid Oxidation. III:1991;239-263 CRC Press, Boca Raton, FL.
12. Van den Ouweland F.A., Eenhoorn P.C., Tan Y., Gribnau F.W.J. Transcutaneous absorption of naproxen gel. Eur. J. Clin. Pharmacol. 36:1989;209-211.
13. Yokomizo Y. Effects of phosphatidylcholine on the percutaneous penetration of drugs throught the dorsal skin of quinea pigs in vitro; and analysis of the molecular mechanism, using attenuated total reflectance-Fourier transform infrared (ATR-FTIR) spectroscopy. J. Control. 42:1996;249-262. Release.
14. Yokomizo Y., Sagitani H. Effects of phospholipids on the percutaneous penetration of indomethacin throught the dorsal skin of guinea pigs in vitro. J. Control. 38:1996a;267-274. Release.
15. Yokomizo Y., Sagitani H. Effects of phospholipids on the in vitro percutaneous penetration of prednisolone and analysis of mechanism by using attenuated total reflectance-fourier transform infrared spectroscopy. J. Pharm. Sci. 85:1996b;1220-1226.
16. Yokomizo Y., Sagitani H. Effects of phospholipids on the percutaneous penetration of indomethacin throught the dorsal skin of quinea pigs in vitro. 2. The effects of the hydrophobic group in phospholipids and a comparison with general enhancers. J. Control. 42:1996c;37-46. Release.